- Home
- VRA vs ALGS Comparison
VRA vs ALGS Comparison
Compare VRA & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- ALGS
- Stock Information
- Founded
- VRA 1982
- ALGS 2018
- Country
- VRA United States
- ALGS United States
- Employees
- VRA N/A
- ALGS N/A
- Industry
- VRA Apparel
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- ALGS Health Care
- Exchange
- VRA Nasdaq
- ALGS Nasdaq
- Market Cap
- VRA 60.6M
- ALGS 53.0M
- IPO Year
- VRA 2010
- ALGS 2020
- Fundamental
- Price
- VRA $2.20
- ALGS $10.20
- Analyst Decision
- VRA Buy
- ALGS Strong Buy
- Analyst Count
- VRA 3
- ALGS 2
- Target Price
- VRA $3.05
- ALGS $60.00
- AVG Volume (30 Days)
- VRA 197.7K
- ALGS 72.5K
- Earning Date
- VRA 09-11-2025
- ALGS 11-05-2025
- Dividend Yield
- VRA N/A
- ALGS N/A
- EPS Growth
- VRA N/A
- ALGS N/A
- EPS
- VRA N/A
- ALGS N/A
- Revenue
- VRA $332,526,000.00
- ALGS $3,174,000.00
- Revenue This Year
- VRA N/A
- ALGS N/A
- Revenue Next Year
- VRA $3.80
- ALGS $28.79
- P/E Ratio
- VRA N/A
- ALGS N/A
- Revenue Growth
- VRA N/A
- ALGS N/A
- 52 Week Low
- VRA $1.71
- ALGS $3.76
- 52 Week High
- VRA $5.99
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- VRA 54.38
- ALGS 52.79
- Support Level
- VRA $1.94
- ALGS $10.66
- Resistance Level
- VRA $2.49
- ALGS $11.65
- Average True Range (ATR)
- VRA 0.15
- ALGS 0.84
- MACD
- VRA 0.02
- ALGS -0.08
- Stochastic Oscillator
- VRA 47.27
- ALGS 15.73
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.